NeuroSense Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRSN and other ETFs, options, and stocks.About NRSN
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS).
CEOAlon Ben-Noon
CEOAlon Ben-Noon
Employees15
Employees15
HeadquartersHerzliya, Tel Aviv
HeadquartersHerzliya, Tel Aviv
Founded2017
Founded2017
Employees15
Employees15
NRSN Key Statistics
Market cap24.45M
Market cap24.45M
Price-Earnings ratio-1.45
Price-Earnings ratio-1.45
Dividend yield—
Dividend yield—
Average volume425.87K
Average volume425.87K
High today$0.8499
High today$0.8499
Low today$0.8114
Low today$0.8114
Open price$0.831
Open price$0.831
Volume206.86K
Volume206.86K
52 Week high$2.60
52 Week high$2.60
52 Week low$0.8114
52 Week low$0.8114
Stock Snapshot
The current NeuroSense Therapeutics(NRSN) stock price is $0.82, with a market capitalization of 24.45M. The stock trades at a price-to-earnings (P/E) ratio of -1.45.
On 2025-12-17, NeuroSense Therapeutics(NRSN) stock traded between a low of $0.81 and a high of $0.85. Shares are currently priced at $0.82, which is +1.3% above the low and -3.3% below the high.
The NeuroSense Therapeutics(NRSN)'s current trading volume is 206.86K, compared to an average daily volume of 425.87K.
During the past year, NeuroSense Therapeutics(NRSN) stock moved between $0.81 at its lowest and $2.60 at its peak.
During the past year, NeuroSense Therapeutics(NRSN) stock moved between $0.81 at its lowest and $2.60 at its peak.
People also own
Based on the portfolios of people who own NRSN. This list is generated using Robinhood data, and it’s not a recommendation.